Patent US4549023A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4549023A Expired / Lapsed US ⏱️ 0.0 years remaining

3-Aminoindazole derivatives

Assignee: Asahi Kasei Corp
•
Filing: 1984-07-31
•
Granted: 1985-10-22
•
Expires: 2004-07-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound of the formula (I): ##STR1## wherein W 1 is a hydrogen atom or a ##STR2## wherein Y is a C 1-6 alkylene group or a C 1-6 alkylene group having a C 1-6 alkyl group substituent; and R 1 and R 2 each independently is a hydrogen atom or a C 1-6 alkyl group and R 1 and R 2 may form a C 4-6 heterocyclic ring or a nitrogen-containing C 4-6 heterocyclic ring together with the adjacent nitrogen atom and the C 4-6 heterocyclic rings may have at least one C 1-6 alkyl group, hydroxyl group or halogen atom; W 2 is a hydrogen atom or a ##STR3## wherein Z is a C 1-6 alkylene group or a C 1-6 alkylene group having a C 1-6 alkyl group substituent; and R 3 and R 4 each independently is a hydrogen atom or a C 1-6 alkyl group and R 3 and R 4 may form a C 4-6 heterocyclic ring or a nitrogen-containing C 4-6 heterocyclic ring together with the adjacent nitrogen atom and the C 4-6 heterocyclic rings may have at least one C 1-6 alkyl group, hydroxyl group or halogen atom; when W 1 is a hydrogen atom, W 2 is the ##STR4## and when W 2 is a hydrogen atom, W 1 is the ##STR5## and the pharmaceutically acceptable acid addition salt thereof.

Inventors

  • 👤 Tadayuki Ibuki
  • 👤 Taisuke Sugihara
  • 👤 Hiromu Kawakubo
  • 👤 Takanori Sone

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 07:54
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/54; C07D231/56; C07D295/00; C07D295/04; C07D295/08; C07D295/084; C07D295/088

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 124 words
A compound of the formula (I): ##STR175## wherein W 1 a ##STR176## wherein Y is a C 1-6 alkylene group or a C 1-6 alkylene group having a C 1-6 alkyl group substituent; and R 1 and R 2 each independently is a hydrogen atom or a C 1-6 alkyl group and R 1 and R 2 may form, together with the adjacent nitrogen atom, either a C 4-6 fully saturated heterocyclic ring or a C 4-6 fully saturated heterocyclic ring containing an additional nitrogen atom, and said fully saturated heterocyclic rings may have at least one C 1-6 alkyl group, hydroxyl group or halogen atom as a substituent thereon; W 2 is a hydrogen atom; or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 124 words
A compound of the formula (I): ##STR175## wherein W 1 a ##STR176## wherein Y is a C 1-6 alkylene group or a C 1-6 alkylene group having a C 1-6 alkyl group substituent; and R 1 and R 2 each independently is a hydrogen atom or a C 1-6 alkyl group and R 1 and R 2 may form, together with the adjacent nitrogen atom, either a C 4-6 fully saturated heterocyclic ring or a C 4-6 fully saturated heterocyclic ring containing an additional nitrogen atom, and said fully saturated heterocyclic rings may have at least one C 1-6 alkyl group, hydroxyl group or halogen atom as a substituent thereon; W 2 is a hydrogen atom; or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 104 words
The compound of claim 1 of the formula (III): ##STR177## wherein Y is a C 1-6 alkylene group or a propylene group having a C 1-4 alkyl group substituent; and R 1 and R 2 each independently is a C 4-6 alkyl group and R 1 and R 2 may form, together with the adjacent nitrogen atom, either a C 4-6 fully saturated heterocyclic ring or a C 4-6 fully saturated heterocyclic ring containing an additional nitrogen atom, and said fully saturated heterocyclic rings may have at least one methyl group, hydroxyl group, chlorine atom, bromine atom, or iodine atom as a substituent thereon.
Claim 4
Dependent Claim 19 words
The compound of claim 2, wherein Y is ethylene group, n-propylene group, n-hexylene group, 3-methylpropylene group or 3-(2-methylpropyl)propylene group.
Claim 5
Dependent Claim 17 words
The compound of claim 3, wherein R 1 and R 2 are both C 4-6 alkyl groups.
Claim 6
Dependent Claim 65 words
The compound of claim 3, wherein R 1 and R 2 form, together with the adjacent nitrogen atom, either a C 4-6 fully saturated heterocyclic ring or a C 4-6 fully saturated heterocyclic ring containing an additional nitrogen atom and the fully saturated heterocyclic rings may have at least one methyl group, hydroxyl group, chlorine atom, bromine atom or iodine atom as a substituent thereon.
Claim 7
Dependent Claim 10 words
The compound of claim 3, wherein ##STR178## is piperidino group.
Claim 8
Dependent Claim 30 words
The compound of claim 2, wherein Y is n-propylene group, and ##STR179## is pyrrolidino group, homopiperidino group, piperazino group, 2-methylpiperidino group, 2,6-dimethylpiperidino group, 4-hydroxypiperidino group, 4-chloropiperido group or 4-methylpiperazino group.

References Cited (Backward Citations)

US28939A Cited
USRE28939E Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-10-21 1989-04-22 1989-10-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-10-21 1993-04-22 1993-10-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-10-21 1997-04-22 1997-10-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag